Transgene and Hypertrust Patient Data Care announce successful go-live of the world’s first blockchain solution for clinical trials of personalized healthcare
Summary
We were very happy to collaborate with Hypertrust Patient Data Care and together set up this novel process, demonstrating once again Transgene’s ability to be at the forefront of innovation”, says Eric Quéméneur, Pharm.D., Ph.D., Executive VP, Chief Scientific Officer of Transgene. Blockchain technologies bring a high level of trust, as it allows a total transparency on how the data were modified throughout the process and provide additional protection in an age of increasing cyberthreats. The decentralized platform leverages blockchain technology, to provide closed-loop supply chain monitoring and orchestration, based on a workflow process definition. Transgene (Euronext: TNG) is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Hypertrust Patient Data Care provides next-generation digital health and supply chain solutions leveraging blockchain, AI and IoT.